Cell-Based Therapies: A New Era in Patient Care Conference :: Nationwide Children's Hospital

Cell-based Therapies: A New Era in Patient Care

October 14, 2013
Register now!

We welcome you to join us to discuss advancements in cellular therapies on October 14, 2013. The Division of Hematology/Oncology/BMT at Nationwide Children's Hospital, the NCI-designated James Comprehensive Cancer Center, the Ohio State University Center of Regenerative Medicine and Cell-Based Therapies, and the International Society of Cellular Therapy have partnered together to bring you this educational experience.

We look forward to presentations given by national speakers from Seattle, Houston, Minneapolis, and Atlanta, who will discuss their research involving chimeric antigen receptor redirected T-cell therapy (CAR T-cells), mesenchymal stromal cells (MSCs), umbilical cord blood cell expansion platforms, and other related topics. These world-class speakers will share their research findings and lead collaborative discussions about advancements occurring in the field of cell-based therapies that are impacting the lives of oncology and stem cell transplant patients.

Who Should Attend
Hematology/Oncology physicians in both pediatrics and adult specialties; nurses and researchers who regularly interact with cancer patients or carry out research studies related to cancer

Continuing Education Credits
The Nationwide Children's Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Nationwide Children's Hospital designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


8:00am – 8:30am

Registration and Continental Breakfast

8:30am – 8:40am


John Barnard, MD
The Research Institute at Nationwide Children's Hospital, Columbus, OH

8:40am – 8:45am

Introduction: Hematopoietic and immune cell therapies

Jeffery Auletta, MD
Nationwide Children's Hospital, Columbus, OH

Steven Devine, MD
The James Comprehensive Cancer Center, Columbus, OH

8:45am – 9:30am

Chimeric antigen receptor (CAR) redirected T-cell therapy
Michael Jensen, MD
Seattle Children's Research Institute, Seattle, WA

9:30am – 10:15am

Viral-specific cytotoxic lymphocyte (CTL) therapy
Ann Leen, PhD
Baylor College of Medicine, Houston, TX

10:15am – 11:00am

Umbilical cord blood cell expansion platforms
Elizabeth J. Shpall, MD
MD Anderson Cancer Center, Houston, TX

11:00am – 11:30am

Speaker panel: Q&A

11:30am – 12:55pm

ISCT lunchworkshop: "Process Development for Cell Therapy Clinical Trials"
Julie Allickson, PhD
Wake Forest Institute for Regenerative Medicine, Winston Salem, NC

Allan Dietz, PhD
Mayo Clinic Center for Regenerative Medicine, Rochester, MN

12:55pm – 1:00pm

Introduction: Non-hematopoietic stem and stromal cell therapies

Thomas Gross, MD, PhD
Nationwide Children's Hospital, Columbus, OH

Lynn O'Donnell, PhD
The James Comprehensive Cancer Center, Columbus, OH

1:00pm – 1:45pm

Mesenchymal stromal cell-based immunomodulation

Jeffery Auletta, MD
Nationwide Children's Hospital, Columbus, OH

1:45pm – 2:30pm

MSC expansion platforms and potency assays
Jacques Galipeau, MD
Emory University, Atlanta, GA

2:30pm – 2:45pm


3:45pm – 3:30pm

Inducible pluripotent stem cells
Jakub Tolar, MD, PhD
University of Minnesota, Minneapolis, MN

3:30pm – 4:15pm

Bringing cell-based therapies into the clinic: an industry perspective on clinical design and academic collaboration
Robert Deans, PhD
Athersys, Cleveland, OH

4:15pm – 4:45pm

Speaker panel: Q&A


Wrap-up and Adjourn

Register now!

For questions or for further information, please contact Professional Conferences Phone Line at (614) 355-0676.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000